MaxCyte
high cell viability and efficiency across a variety of cell types | MaxCyte
Company
Deck Type
IPO
Sector
Industry
Deck date
July 2021
Slide
31 of 34
Related slides by other companies
Cytek
Investor Day
June 2022
advancing cell analysis with our unique technology | Cytek
Exscientia
Results
May 2022
the exalt trial i a be | Exscientia
Cytek
Investor Presentation
November 2022
advancing cell analysis with our unique technology | Cytek
Genprex
Investor Presentation
November 2024
induced generation of functional insulin expressing cells from alpha cells in human islets | Genprex
Other recent decks by MaxCyte
See all presentations (8 decks)
Investor Presentation
January 2024
Results
November 2023
Investor Presentation
October 2023
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights